Schizophrenia Clinical Trial
Official title:
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
Our team will develop a prototype game (OnTrack>The Game) in which users play the role of a
person who has experienced First Episode Psychosis and move through animated role-playing
scenarios, learning practical tips for engaging in care, playing mini-games to develop self-
advocacy skills, and seeing stories of hope and recovery (brief video vignettes). The game
is designed in an engaging comic book style in which the player is presented with realistic
situations designed to promote engagement and the development of trusting relationships.
Following development of the prototype, the investigators will conduct a pilot study to
develop preliminary data to determine feasibility of a large-scale Phase 2 effectiveness
study. This pilot study aims to demonstrate proof of concept for OnTrack>The Game. The
investigators will recruit a sample of patients/consumers (n=25) from OnTrackNY sites that
offer services for those experiencing their first psychotic episode. Quantitative data will
be collected through baseline and follow up surveys that utilize instruments to measure
knowledge and attitudes about recovery, perceptions of stigma, feelings of empowerment and
sense of hopefulness. The investigators will also conduct semi-structured interviews with a
subset of participants to explore engagement in treatment and attitudes toward the game.
Status | Completed |
Enrollment | 19 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 30 Years |
Eligibility |
Inclusion Criteria (Consumers): - 18 - 30 years of age; - have experienced a first episode of psychosis; - have been referred to OnTrack New York in the past 12 months; - are willing to complete study requirements; and - provides informed consent Exclusion Criteria (Consumers): - non-English speaker; - not clinically stable (at risk of self harming or others, and/or experiencing elevated symptoms) and incapable of providing informed consent |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | Center for Social Innovation | Needham | Massachusetts |
United States | New York State Psychiatric Institute | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Center for Social Innovation, Massachusetts | Research Foundation for Mental Hygiene, Inc. |
United States,
Borkin, J. R., Stefffen, J. J., Ensfield, K. K., Wishnick, H., Wilder, K. & Yangarber, N. (2000) Recovery attitudes questionnaire: Development and evaluation. Psychiatric Rehabilitation Journal, 24(2), 95-102
Corrigan, P. W., Michaels, P. J., Vega, E., Gause, M., Watson, A. C. & Rusch, N. (2012) Self-stigma of mental illness scale-short form: Reliability and validity. Psychiatric Services, 48(8), 1042-1047.
Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992 Oct;17(10):1251-9. — View Citation
Rogers ES, Chamberlin J, Ellison ML, Crean T. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv. 1997 Aug;48(8):1042-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in attitudes toward recovery | The Herth Hope Index (HHI) will be employed to assess hope in adults immediately before (Month 9; week 36) and 2 weeks (Month 10; week 40) following game play. The instrument is a 12-item survey adapted from the Herth Hope Scale (HHS) (Herth, 1992). The Recovery Attitudes Questionnaire (RAQ-16) will also be used, which helps consumers identify and think about their beliefs and attitudes toward recovery. The instrument is a 16-item survey that will be employed immediately before (week 36) and 2 weeks after game play (week 40) (Borkin et al, 2000). | Pre and post game play; timeframe: Months 9 and 10 (weeks 36 and 40) | No |
Secondary | Sense of stigma and empowerment | (1) The self-stigma of mental illness survey (short form) (Corrigan et al, 2012) and (2) empowerment survey will be used both immediately before game play (weeks 36) and 2-weeks (week 40) following game play (Rogers, 1997). | Month 10 (week 40) | No |
Secondary | Increased engagement in treatment | Semi-structured interviews will be conducted with a subset of participants to explore access to treatment and potential barriers. | Post game play; timeframe: Month 10 (week 40) | No |
Secondary | Attitudes toward the game | Semi-structured interviews will take place with a subset of participants to explore their experience playing the game and attitudes toward it (e.g. extent to which they can relate to it; satisfaction; usability). | Post game play; timeframe: Month 10 (week 40) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |